Medicine guide

Clindamycin [Phosphat]-Mepha i.v./i.m. 600 mg/4 ml

As listed in the register: Clindamycin [Phosphat]-Mepha i.v./i.m. 600 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung i.v. / Injektionslösung i.m.

600 mg/4 ml ·

  • Prescription only
  • Antibiotics, antivirals and antifungals taken into the body
Active substance
Clindamycinum
Made by
Mepha Pharma AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Infektionskrankheiten

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byMepha Pharma AG
Active substanceClindamycinum
Used inAntibiotics, antivirals and antifungals taken into the body
Strength600 mg/4 ml
ClassificationJ01FF01 · Antibiotics, antivirals and antifungals taken into the body
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerClindamycin [Phosphat]-Mepha i.v./i.m. 600 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung i.v. / Injektionslösung i.m.
Packs5 x 4 ml Ampulle(n) · 5 x 5 x 4 ml Ampulle(n)
Zulassungsnummer62981
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.